Detalles de la búsqueda
1.
Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone.
Haematologica
; 102(1): 168-175, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27540138
2.
The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma.
Haematologica
; 102(12): 2113-2124, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860344
3.
The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care.
Clin Cancer Res
; 23(1): 225-238, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27440267
4.
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
J Hematol Oncol
; 10(1): 127, 2017 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28633670
5.
Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
Diagn Microbiol Infect Dis
; 68(3): 214-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20955912
Resultados
1 -
5
de 5
1
Próxima >
>>